ALDARA

This brand name is authorized in Austria, Australia, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Mexico, Netherlands, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug ALDARA contains one active pharmaceutical ingredient (API):

1 Imiquimod UNII P1QW714R7M - IMIQUIMOD

Imiquimod is an immune response modifier. Saturable binding studies suggest a membrane receptor for imiquimod exists on responding immune cells. Imiquimod has no direct antiviral activity. Read about Imiquimod

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ALDARA Cream	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D06BB10	Imiquimod	D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06B Chemotherapeutics for topical use → D06BB Antivirals
Discover more medicines within D06BB10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10106X, 2546B, 2637T, 4134N, 4559Y
Country: CA	Health Products and Food Branch	Identifier(s): 02239505
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 2487-MEE-0916, 3022-MEE-0917
Country: EE	Ravimiamet	Identifier(s): 1060322, 1471306
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 98080001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 452862
Country: FR	Base de données publique des médicaments	Identifier(s): 66916232
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 138260, 161365, 178955, 40227
Country: HK	Department of Health Drug Office	Identifier(s): 44090
Country: IE	Health Products Regulatory Authority	Identifier(s): 11014, 11138, 11181, 11601, 11619, 11635
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4005
Country: IT	Agenzia del Farmaco	Identifier(s): 034405011
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1027347, 1063631
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 524M98
Country: NL	Z-Index G-Standaard	Identifier(s): 14331969
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 55050
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100094245
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W69278001
Country: SG	Health Sciences Authority	Identifier(s): 10105P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 23763011
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8698856350091, 8698856350435, 8698856350633
Country: US	FDA, National Drug Code	Identifier(s): 99207-260
Country: ZA	Health Products Regulatory Authority	Identifier(s): 32/34/0541